InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
Globe Newswire•17/11/2026•16:30 ET
0
Key Highlights
- ➤CGuard Prime TCAR system received FDA approval on November 9, 2026
- ➤CGuard Prime previously received FDA approval for transfemoral CAS in June 2025
- ➤TCAR and CAS comprise approximately 75,000 U.S. procedures annually, company estimates
- ➤InspireMD will host six physician experts for a November 19 KOL webinar
Participating KOLs include six leading physician experts representing vascular surgery, interventional cardiology, vascular medicine, and neurosurgery
Webinar to take place on Thursday, November 19, 2026 at 4:30 p.m. EST
Get started
Create a free account to read the full story.
